Novartis Pharmaceuticals

About Novartis Pharmaceuticals

Novartis is an innovative medicines company dedicated to reimagining medicine to improve and extend people's lives. Their mission is to empower patients, healthcare professionals, and societies in the face of serious diseases, with their medicines reaching 296 million people worldwide.

Products & Services

Innovative Medicines: Medicines addressing society's greatest disease burdens to restore possibility for patients.

Therapeutic Areas: Focused on Cardiovascular, Renal and Metabolic; Immunology; Neuroscience; and Oncology.

Specific Products: Rhapsido® (remibrutinib) for chronic spontaneous urticaria (CSU), Cosentyx® (secukinumab) with a direct-to-patient platform in the US, and Zolgensma® with a Global Managed Access Program (gMAP).

Novartis Gene Therapies: Specialized therapies for genetic conditions.

Pipeline: A range of investigational drugs and therapies in development.

Specialties

Innovative Medicines Cardiovascular, Renal and Metabolic Diseases Immunology Neuroscience Oncology Gene Therapies Global Health Research and Development

Funding History

No funding data available

This company may be bootstrapped or privately funded

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

G

Giovanni Caforio

Chair

S

Simon Moroney

Vice-Chair, Board of Directors

N

Nancy C. Andrews

M.D., Ph.D.

T

Ton Buechner

Board member

P

Patrice Bula

Lead Independent Director

E

Elizabeth (Liz) Doherty

Audit Committee Financial Expert

View 30 more team members with Pro

Unlock Full Team Directory

Recent News